A quality apheresis collection is often the critical first step in the development of today's innovative immunotherapy treatments. Discover the Spectra Optia® Apheresis System and how it delivers high target cell collection with low non-target cell contamination, driving consistency and reproducibility. All backed by Terumo BCT's more than 30 years of experience in apheresis collection technology.
The Elutra® Cell Separation System provides a standardized and consistent method for separating cell populations, making it well-suited for the enrichment of lymphocytes prior to isolation and expansion for T-cell therapies. The Elutra system offers greater than 65 percent recovery of both monocytes and lymphocytes, as well as greater than 75 percent purity.2
The Quantum® Cell Expansion System provides a solution for expansion of cells used in adoptive transfer therapies, including promising work in the area of T-cell therapies. The Quantum system has also been used to produce viral vectors, including lentivirus, and to support other areas of cancer research, such as the expansion of stable tumor lines and ex vivo maturation of dendritic cells.3
Products available in select markets.